TI
Touchstone Innovations
Venture CapitalActiveTouchstone Innovations creating, building and investing in early-stage technology companies.
18
Investments
5
Exits
£250M
AUM
27.8%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Touchstone Innovations.
Investment Thesis & Strategy
Touchstone Innovations invests in early-stage fintech companies, focusing on building and creating new ventures. They invest across various stages, supporting the development of innovative technology businesses.
Investment Activity
Deals per year over the last 7 years
5
20152
20160
20172
20180
20191
20202
2021Portfolio Companies
Selected investments from their portfolio of 18 companies
P
Peptone
Biotech · Series A, 2021
C
Cellares
Biotech · Series B, 2021
B
Baseimmune
Biotech · Seed, 2020
N
Nu Quantum
Other · Seed, 2018
R
Refeyn
Biotech · Series A, 2018
G
Graphcore
AI/ML · Series A, 2016
M
Mind Foundry
AI/ML · Series A, 2016
O
Oxbotica
Robotics · Series A, 2015
O
Oxehealth
Healthcare · Series A, 2015
T
Tractable
AI/ML · Series A, 2015
D
DnaNudge
Healthcare · Series A, 2015
S
Seldon
AI/ML · Series A, 2015
Notable Exits
CompanyTypeYearValue / Acquirer
GraphcoreAcquisition2024—
KymabAcquisition2021$1.1B
Autifony TherapeuticsAcquisition2021—
ImmunocoreIPO2021$2.3B
Heptares TherapeuticsAcquisition2015$400M
Frequently Asked Questions
Touchstone Innovations focuses on Series A, Series B, Series C+ stage investments.